SEC Form 4 · accession 0001127602-15-023479
BIOGEN INC. · BIIB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stelios Papadopoulos
Director
Period of report
Jul 27, 2015
Accepted (ET)
Jul 27, 2015 · 5:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875045
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jul 27, 2015 | P | 5,000 | $304.776 | A | 5,000 | I | Esperanza Holdings, LLC |
| Common StockF1,F3 | Jul 27, 2015 | P | 5,000 | $304.979 | A | 5,000 | I | Stelios Holdings, LLC |
| Common Stock | holding | — | — | — | 16,580 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Full information regarding the number of shares purchased at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
- F2This represents the weighted average price for shares purchased at a range between $304.745 (low) and $304.939 (high).
- F3This represents the weighted average price for shares purchased at a range between $304.978 (low) and $304.98 (high).